Login

Isabelle C. Guarneri

ORCID: 0000-0001-8993-064X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5083567630
Research Areas
  • Long-Term Effects of COVID-19
  • COVID-19 Clinical Research Studies
  • Pharmacological Receptor Mechanisms and Effects
  • Inflammation biomarkers and pathways

Universidade de Ribeirão Preto
 2020-2021

Universidade de São Paulo
 2020-2021

 Cholinergic and lipid mediators crosstalk in Covid-19 and the impact of glucocorticoid therapy
OPENALEX - Publications 
Malena M. Pérez Vinícius E. Pimentel Carlos Alessandro Fuzo Pedro V. da Silva‐Neto Diana Mota Toro and 43 more Camila Oliveira Silva Souza Thais Fernanda de Campos Fraga‐Silva Luiz Gustavo Gardinassi Jonatan C. S. de Carvalho Nicola T. Neto Ingryd Carmona‐Garcia Camilla N. S. Oliveira Cristiane M. Milanezi Viviani Nardini Takahashi Thaís Canassa De Léo Lílian Cataldi Rodrigues Cassia F. S. L. Dias Ana C. Xavier Giovanna da Silva Porcel Isabelle C. Guarneri Kamila Zaparoli Caroline T. Garbato Jamille Guedes Malta Argolo Angelo Alves Ferreira Júnior Marley Ribeiro Feitosa Rogério Serafim Parra José Joaquim Ribeiro da Rocha Omar Féres Fernando Crivelenti Vilar Gilberto Gambero Gaspar Rafael Carlos da Silva Leticia F. Constant Fátima M. Ostini Alessandro P. de Amorim Augusto M. Degiovani Dayane P. da Silva Debora C. Nepomuceno Rita C. C. Barbieri Isabel Kinney Ferreira de Miranda Santos Sandra Regina Maruyama Elisa Maria de Sousa Russo Angelina Lettiere-Viana Ana Paula Fernandes Vânia Luiza Deperon Bonato Cristina Ribeiro de Barros Cardoso Carlos A. Sorgi Marcelo Dias‐Baruffi Lúcia Helena Faccioli

Abstract Cytokine storms and hyperinflammation, potentially controlled by glucocorticoids, occur in COVID-19; the roles of lipid mediators acetylcholine (ACh) how glucocorticoid therapy affects their release Covid-19 remain unclear. Blood bronchoalveolar lavage (BAL) samples from SARS-CoV-2- non-SARS-CoV-2-infected subjects were collected for metabolomic/lipidomic, cytokines, soluble CD14 (sCD14), ACh, CD36-expressing monocyte/macrophage subpopulation analyses. Transcriptome reanalysis...

10.1101/2021.01.07.20248970 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2021-01-09
 Prognostic value of sTREM-1 in COVID-19 patients: a biomarker for disease severity and mortality
OPENALEX - Publications 
Pedro V. da Silva‐Neto Jonatan C. S. de Carvalho Vinícius E. Pimentel Malena M. Pérez Ingryd Carmona‐Garcia and 41 more Nicola T. Neto Diana Mota Toro Camilla N. S. Oliveira Thais Fernanda de Campos Fraga‐Silva Cristiane M. Milanezi Lílian Cataldi Rodrigues Cassia F. S. L. Dias Ana C. Xavier Giovanna da Silva Porcel Isabelle C. Guarneri Kamila Zaparoli Caroline T. Garbato Jamille Guedes Malta Argolo Angelo Alves Ferreira Júnior Alessandro P. de Amorim Augusto M. Degiovani Dayane P. da Silva Debora C. Nepomuceno Rafael Carlos da Silva Leticia F. Constant Fátima M. Ostini Marley Ribeiro Feitosa Rogério Serafim Parra Fernando Crivelenti Vilar Gilberto Gambero Gaspar José Joaquim Ribeiro da Rocha Omar Féres Rita C. C. Barbieri Fabiani Gai Frantz Sandra Regina Maruyama Elisa Maria de Sousa Russo Angelina Lettiere-Viana Ana Paula Fernandes Isabel Kinney Ferreira de Miranda Santos Vânia Luiza Deperon Bonato Marcelo Dias‐Baruffi Adriana Malheiro Ruxana T. Sadikot Cristina Ribeiro de Barros Cardoso Lúcia Helena Faccioli Carlos A. Sorgi

Abstract Background The uncontrolled inflammatory response plays a critical role in the novel coronavirus disease (COVID-19) and triggering receptor expressed on myeloid cells-1 (TREM-1) is thought to be intricate signal amplification. This study aims investigate association between soluble TREM-1 (sTREM-1) COVID-19 as prognostic biomarker predict severity, lethality clinical management. Methods We enrolled 91 patients with domiciliary care (44 patients) or hospital (47 patients), who were...

10.1101/2020.09.22.20199703 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-09-23
Coming Soon ...